A drug originally designed as cancer therapy virtually eliminated allergic reactions in moderate cases and significantly lessened the risk of death in severe cases, according to a new study in animal models.
A specialized subset of rare immune cells called plasmacytoid dendritic cells may promote antitumor immunity, according to a Northwestern Medicine study published in the Journal of Clinical Investigation.
A recent study has found that the gallbladder may play a crucial role in the transmission of a common infection found in hospital settings, according to findings published in Nature Communications.
The safety of a new therapy for an aggressive brain tumor was demonstrated in a recent clinical trial, and the drug also cleared other important hurdles.
In a new clinical exposure program, doctoral students in the Driskill Graduate Program in Life Sciences partner with clinicians at Lurie Children’s Hospital to forge connections between basic and clinical research efforts.
Northwestern Medicine scientists have identified a novel strategy that could improve the efficacy of immunotherapy in treating chronic viral infections.
According to a recent study, Northwestern scientists have pinpointed how an ectoenzyme called CD73 undermines the effectiveness of an emerging cancer therapy.
Subcutaneous fat cells in mice expanded after a gene transcription factor was deleted, according to a new study published in Cell Reports.
A one-time stem cell transplantation therapy for multiple sclerosis showed improvements over the current treatment, according to a preliminary trial.
A human protein called RBBP6 helps fight the Ebola virus by interfering with the virus replication cycle, according to a study recently published in Cell.